MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Lupin
Lupin
BSE: 500257|NSE: LUPIN|ISIN: INE326A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 31, 14:06
533.45
4.4 (0.83%)
VOLUME 12,134
LIVE
NSE
May 31, 14:06
533.45
4.4 (0.83%)
VOLUME 165,435
Earnings News on Lupin
Select Year: 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2000-2004
Lupin to focus on new product infusion in FY13 

5.48 pm | 10 May 2012 |  Source: CNBC-TV18

Higher tax expenses led to a decline in consolidated net profit of pharma company, Lupin in the fourth quarter of FY12. The company posted a decline o...

Lupin Q4 cons net profit declines 31% as tax expenses rise 

3.46 pm | 10 May 2012 |  Source: Moneycontrol.com

Pharma company Lupin's fourth quarter consolidated net profit declined 31% year-on-year to Rs 156 crore due to higher tax expenses....

Lupin Q4 PAT seen up 17.8% at Rs 267 cr 

9.39 am | 10 May 2012 |  Source: CNBC-TV18

Pharmaceutical company Lupin is expected to report a growth of 17.9% year-on-year and 14% quarter-on-quarter in its profit after tax of Rs 267 crore f...

Lupin Dec '11 sales at Rs 1,405.38 crore 

3.14 pm | 25 Jan 2012 |  Source: Moneycontrol.com

Lupin has reported a sales turnover of Rs 1,405.38 crore and a net profit of Rs 214.61 crore for the quarter ended Dec '11...

Could exceed earlier outlined guidance: Lupin 

3.38 pm | 24 Jan 2012 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Dr Kamal K Sharma, managing director, Lupin said, the company will be able to maintain its performance during the year. ...

Lupin Q3 cons net up 5% YoY at Rs 235 cr 

2.56 pm | 24 Jan 2012 |  Source: Moneycontrol.com

Pharma company Lupin's consolidated net profit for the third quarter rose 5% year-on-year at Rs 235.1 crore as strong sales growth was offset by highe...

Lupin Q3 PAT seen up 4% to Rs 233 cr 

10.00 am | 24 Jan 2012 |  Source: CNBC-TV18

Lupin is expected to report a profit after tax of Rs 233 crore in the quarter ended December FY12, a moderate growth of 4% as compared to Rs 224 crore...

Q2 report card: Pharma sector posts encouraging numbers 

10.32 pm | 02 Dec 2011 |  Source: CNBC-TV18

After a sluggish first quarter, pharma universe reported some encouraging numbers in the second quarter. This is with some support from stable growth ...

1
Quick Links for Lupin
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.